Ceftacrit-TZ Injection
Ceftacrit-TZ Injection is a broad-spectrum antibacterial combination of Ceftazidime, a third-generation cephalosporin, and Tazobactam, a beta-lactamase inhibitor. This formulation is designed to effectively treat moderate to severe bacterial infections, including those caused by beta-lactamase-producing organisms.
Ceftazidime works by inhibiting bacterial cell wall synthesis, while Tazobactam enhances its activity by preventing enzymatic degradation. Together, they provide extended antibacterial coverage, particularly against gram-negative pathogens, making Ceftacrit-TZ suitable for challenging and resistant infections.
It is commonly indicated for the treatment of respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and hospital-acquired infections. The injection is intended for IM/IV use only and is supplied as a single-use vial, ensuring accurate dosing and safety in clinical settings.
Manufactured under stringent quality standards, Ceftacrit-TZ Injection offers high purity, stability, and consistent therapeutic performance, making it a reliable choice for hospitals and healthcare professionals.
Key Features:
- Ceftazidime & Tazobactam Injection 2.25 g
- Broad-spectrum antibacterial coverage
- Effective against resistant bacterial strains
- For IM/IV use only | Single-use vial
- Ideal for serious and hospital-based infections
Ceftacrit-TZ Injection supports effective infection control and improved patient outcomes through dependable antibiotic therapy.
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.